Cohance Lifesciences Ltd. Financials

15:59 Jun 18

Cohance Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1009.60
+14.50 (+1.46%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Cohance Lifesciences Ltd. Financials

Cohance Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1009.60
+14.50 (+1.46%)
15:59 Jun 18
Quality
image/svg+xml

39/100
Medium Financial Strength

Valuation
image/svg+xml

23/100
Expensive Valuation

Technical

30/100
Technically Bearish

Strength

4

Weakness

8

Opportunity

0

Threats

1

15.78 %

ROE %

8.83 %

ROA %

10.52

EPS

66.64

BVPS

22.36 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1009.72 1320.22 1340.33 1051.35 1197.58
Operating Expenses +
569.24 740.79 773.79 645.54 822.38
Raw Material
310.32 459.46 430.08 265.88 222.66
Increase Decrease in Cost
-8.37 -60.35 -20.94 49.16 82.63
Other Manufacturing Expense
122.73 173.19 176.29 133.48 0
Employee Cost
87.29 100.48 110.51 135.92 249.56
Miscellaneous Expenses
57.27 68.01 77.85 61.1 267.53
Operating Profit
440.48 579.43 566.54 405.81 375.2
Other Income
14.24 92.38 46.36 61.91 58.56
Depreciation
31.64 39.1 47.73 54.6 77.49
Interest
9.14 6.23 5.44 7.45 12.35
Profit before tax and exceptio..
413.94 626.48 559.73 405.67 343.92
Exceptional Items
0 0 0 0 0
PBT
413.94 626.48 559.73 405.67 343.92
Provision for Taxation
105.33 213.78 148.44 105.39 79.15
Net Profit
308.61 412.69 411.29 300.28 264.77
NET Profit after MI
362.34 453.8 411.29 300.28 267.87
EPS
14.23 17.83 16.16 11.8 10.45
Operating Profit Margin (%)
43.62 43.89 42.27 38.6 31.33
Net Profit Margin (%)
35.89 34.37 30.69 28.56 22.37

Cohance Lifesciences Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 50.10 50.10 50.10 50.10 50.10
FII 11.00 10.80 10.70 9.80 9.50
MF 13.00 13.20 14.10 14.80 15.30
Others 3.70 3.50 2.80 2.60 2.00
Shareholder Shares Holding %
Download Our App On: